Research Articles & Guides
In-depth research guides, compound breakdowns, and scientific context for UK researchers. All content is for educational and research purposes only.
HCG Research Guide UK 2026: Gonadotropin Studies Purity Standards & Applications
Your guide to hCG in the UK: research, purity, and where to buy HCG UK. Learn about its uses and standards.
Ram Goldman · 12 June 2026 · 19 min read
Ram Goldman · 12 June 2026 · 12 min read
Research Peptides UK: What They Are How They're Tested & What to Look For
Research peptides UK: What they are, how they're tested, and what to look for when buying.
Ram Goldman · 12 June 2026 · 3 min read
Multiple Athletes Face Doping Bans for Ipamorelin Use
Explore the recent doping scandals involving Ipamorelin, leading to suspensions for UFC fighter David Branch, NBA player Wilson Chandler, and weightlifter Alexei Lovchev.
Ram Goldman · 11 June 2026 · 2 min read
Tesamorelin: A Peptide Under Scrutiny for Cognitive and Endocrine Enhancements
Explore the latest research on tesamorelin, a peptide showing promise for cognitive enhancement and endocrine system support, including its use in laboratory research and potential synergies with other peptides.
Ram Goldman · 11 June 2026 · 21 min read
Best Peptides for Cognitive Research 2026: Semax Selank & Nootropic Studies
Explore Semax, Selank, and other cognitive research peptides UK. Learn about their mechanisms and uses in 2026.
Ram Goldman · 11 June 2026 · 3 min read
Tesamorelin Offers New Hope for HIV Patients Battling Visceral Fat and Liver Disease
Discover how tesamorelin, now available as Egrifta WR™, is making strides in reducing visceral fat and combating liver disease in individuals living with HIV, offering improved health and convenience.
Ram Goldman · 11 June 2026 · 2 min read
GHK-Cu: A New Frontier in Erectile Dysfunction and Vascular Health?
Explore the emerging debate surrounding GHK-Cu's potential to treat erectile dysfunction and enhance vascular health, examining its regenerative properties and future research directions.
Ram Goldman · 11 June 2026 · 18 min read
Longevity Research Peptides UK 2026: NAD+ MOTS-c & GHK-Cu Cluster Guide
Explore longevity peptides UK in 2026: NAD+, MOTS-c, and GHK-Cu. Your guide to cellular health and anti-ageing.
Ram Goldman · 11 June 2026 · 3 min read
Copper Peptide Breakthrough: Nasal Sprays and Novel Delivery Methods Spark New Health and Anti-Aging Interest
Explore the emerging potential of GHK-Cu copper peptide nasal sprays and other innovative delivery methods for anti-aging, cognitive health, and tissue repair.
Ram Goldman · 10 June 2026 · 3 min read
Eli Lilly's Retatrutide Achieves Remarkable Weight Loss in Landmark Phase 3 Trial
Eli Lilly's investigational drug retatrutide shows remarkable weight loss results in Phase 3 trials, with potential for significant cardiometabolic improvements.
Ram Goldman · 10 June 2026 · 17 min read
How to Reconstitute Research Peptides: Step-by-Step Guide with Bacteriostatic Water
Learn how to reconstitute peptides using bacteriostatic water with this step-by-step guide. Keep your research compounds stable.
Ram Goldman · 10 June 2026 · 4 min read
MOTS-c Peptide: Unpacking the Science Behind Mitochondrial Signaling and Therapeutic Potential
Explore the latest research and therapeutic potential of the MOTS-c peptide, a mitochondrial-derived signaling molecule, and understand its implications for metabolic health and longevity.
Ram Goldman · 10 June 2026 · 2 min read
Breakthrough Peptide MOTS-c Shows Dual Promise for Cancer and Metabolic Health
Discover how the MOTS-c peptide is showing significant promise in developing new treatments for both cancer and metabolic health issues, according to recent research.
Ram Goldman · 10 June 2026 · 49 min read
5-Amino-1MQ Research Guide UK 2026: NNMT Inhibition & Metabolic Studies
5-Amino-1MQ UK research guide: NNMT inhibition, metabolic studies, safety, and legal status in 2026.
Ram Goldman · 10 June 2026 · 3 min read
Unlocking Peak Performance: How MOTS-c Peptide Boosts Exercise and Fortifies Bones
Discover how the mitochondrial peptide MOTS-c enhances exercise performance, supports muscle and bone health, and regulates metabolism, according to recent scientific studies.
Ram Goldman · 9 June 2026 · 3 min read
Breakthrough Peptide MOTS-c Shows Promise in Combating Diabetes and Enhancing Pancreatic Health
Discover how the mitochondrial peptide MOTS-c is showing remarkable promise as a therapeutic agent for diabetes, by preventing pancreatic beta-cell senescence and improving metabolic health.
Ram Goldman · 9 June 2026 · 15 min read
KPV Peptide Research Guide UK 2026: Anti-Inflammatory Studies & Applications
Explore KPV peptide UK: anti-inflammatory research, uses, and how to access KPV in the UK by 2026.
Ram Goldman · 9 June 2026 · 3 min read
New Research Uncovers Link Between MOTS-c Levels and Polycystic Ovary Syndrome
New research reveals a significant link between lower MOTS-c levels in serum and skeletal muscle and Polycystic Ovary Syndrome (PCOS), suggesting a role for mitochondrial dysfunction in the condition.
Ram Goldman · 9 June 2026 · 2 min read
New Research Tool Aims to Advance Obesity and Weight Loss Studies
Umbrella Labs introduces 5-amino-1MQ, a research chemical for studying NNMT pathways, potentially impacting obesity and weight loss research. New studies suggest NNMT inhibition may enhance muscle function.
Ram Goldman · 9 June 2026 · 15 min read
MOTS-c Peptide Research Overview 2026: Mitochondrial Metabolism & UK Availability
MOTS-c UK research overview for 2026. Learn about mitochondrial metabolism, availability, and research potential in the UK.
Ram Goldman · 9 June 2026 · 2 min read
The Double-Edged Sword: hCG's Role in Male Sexual Health and Controversies
Explore the advancements and controversies surrounding the use of hCG in male sexual health, including its effects on testosterone, fertility, and the unproven claims of penis enlargement.
Ram Goldman · 8 June 2026 · 3 min read
The Peptide Problem: Hype Outpaces Evidence for Popular Injectables
Explore the growing trend of injectable peptides like TB-500, the significant gap between their purported benefits and scientific evidence, and the serious safety concerns raised by regulatory bodies.
Ram Goldman · 8 June 2026 · 18 min read
NAD+ Peptide Research Guide UK 2026: Cellular Energy Longevity & Key Studies
Explore NAD+ peptide UK research in 2026. Understand cellular energy, longevity, and key studies on NMN & NR. Essential for researchers.
Ram Goldman · 8 June 2026 · 3 min read
Exploring the Link Between TB-500 and Erectile Dysfunction: A Look at the Evidence
An examination of the current evidence and user reports concerning the potential effects of TB-500 on erectile dysfunction, highlighting the need for further scientific research.
Ram Goldman · 8 June 2026 · 3 min read
Peptide Power Duo: TB-500 and BPC-157 Synergy Explored for Enhanced Recovery
Explore the potential synergistic benefits of combining TB-500 and BPC-157 peptides for enhanced tissue repair, recovery, and regeneration, as highlighted in recent scientific discussions.
Ram Goldman · 8 June 2026 · 19 min read
GHK-Cu (Copper Peptide) Research Guide UK 2026: Collagen Skin & Wound Studies
GHK-Cu UK: Explore research on collagen synthesis, skin regeneration, and wound healing. Discover its anti-aging benefits and mechanism of action.
Ram Goldman · 8 June 2026 · 3 min read
TB-500: Unlocking the Potential for Tissue Repair and Regeneration
Explore the latest research on TB-500, a synthetic peptide derived from Thymosin beta-4, and its potential roles in tissue repair, wound healing, and regeneration.
Ram Goldman · 7 June 2026 · 3 min read
Umbrella Labs Enhances BPC-157 Research Access with New Liquid Spray Format
Umbrella Labs expands access to BPC-157 research with a new liquid spray format, enhancing precision and quality control for laboratory studies. Learn about its applications and quality assurance measures.
Ram Goldman · 7 June 2026 · 17 min read
CJC-1295 No DAC Research Guide UK: Mechanism Half-Life & Protocol Notes
Explore CJC-1295 No DAC UK: mechanism, half-life, and research protocols. Understand its benefits for GH & IGF-1.
Ram Goldman · 7 June 2026 · 3 min read
The BPC-157 Phenomenon: A Wellness Miracle or a Risky Gamble?
Explore the growing phenomenon of BPC-157 in the wellness industry. Learn about its purported benefits, the scientific evidence (or lack thereof), regulatory concerns, and the risks associated with this popular peptide.
Ram Goldman · 7 June 2026 · 3 min read
FDA Considers Easing Peptide Restrictions Amidst Wellness Craze
The FDA is reviewing restrictions on popular peptides like BPC-157, potentially allowing compounding pharmacies to produce them amidst growing wellness demand, sparking debate over safety and access.
Ram Goldman · 7 June 2026 · 19 min read
Buy Retatrutide UK: Research Overview Purity Standards & Sourcing Guide 2026
Buy Retatrutide UK: Your 2026 guide to purity standards, authentic UK sources, and sourcing high-quality research peptides. Learn what to look for.
Ram Goldman · 7 June 2026 · 3 min read
Eli Lilly's Retatrutide Achieves Remarkable Weight Loss in Phase 3 Trials, Matching Bariatric Surgery Outcomes
Eli Lilly's retatrutide shows remarkable weight loss results in Phase 3 trials, with up to 30.3% reduction, comparable to bariatric surgery. Learn more about the efficacy and safety of this investigational drug.
Ram Goldman · 6 June 2026 · 3 min read
AI Revolutionises Peptide Drug Discovery, Accelerating Treatments for Superbugs
Explore how artificial intelligence is revolutionizing peptide drug discovery, leading to faster development of treatments against antibiotic-resistant bacteria like MRSA and Acinetobacter baumannii.
Ram Goldman · 6 June 2026 · 20 min read
Selank vs Semax: UK Researcher's Comparison Guide (2026)
Compare Selank vs Semax UK research peptides. Understand mechanisms, applications, and quality assurance for UK researchers.
Ram Goldman · 6 June 2026 · 3 min read
Global Pharmaceutical Giants Bolster Peptide Capabilities Amidst Market Expansion
Explore the latest developments in the global pharmaceutical industry as major companies expand their peptide research, manufacturing, and market presence, driven by strategic acquisitions and market growth.
Ram Goldman · 6 June 2026 · 4 min read
The Risky Peptide Trend: Youth Turn to Unregulated Injections Fueled by Social Media
Explore the growing trend of young people injecting unregulated peptides, driven by social media and influencers, and the significant health risks involved.
Ram Goldman · 6 June 2026 · 21 min read
TB-500 vs BPC-157: Which Peptide for Which Research Application?
Compare TB-500 vs BPC-157: mechanisms, applications, evidence, and safety for research. Discover which peptide suits your needs.
Ram Goldman · 6 June 2026 · 3 min read
Peptide Boom Fuels $100 Million Gray Market, Driven by Crypto and 'Looksmaxxing' Trend
Explore the booming $100 million gray market for peptides, driven by cryptocurrency and the 'looksmaxxing' trend, and the growing regulatory concerns.
Ram Goldman · 5 June 2026 · 20 min read
BPC-157 UK: Complete Research Guide for 2026
Buy BPC-157 UK: Your comprehensive guide to research-grade peptides. Learn about quality, legality, and safe sourcing for UK researchers.

My Store Admin · 4 June 2026 · 6 min read
Where and How to Buy Retatrutide Peptide: A 2026 Guide

My Store Admin · 1 June 2026 · 11 min read
Retatrutide Side Effects: Detailed Guide with Clinical Trial Insights 2026

My Store Admin · 1 June 2026 · 9 min read
5-Amino-1MQ: Mechanism, Benefits, Dosage & Stacking Guide 2026

My Store Admin · 29 May 2026 · 7 min read
The Ultimate Guide to Ipamorelin Therapy: Benefits, Effects & Uses 2026

My Store Admin · 26 May 2026 · 10 min read
Comprehensive Guide to Tesamorelin Therapy: Uses, Effects & Safety in 2026

My Store Admin · 23 May 2026 · 4 min read
Human Growth Hormone Explained: Benefits, Risks & HGH Peptide Therapy Guide 2026

My Store Admin · 23 May 2026 · 12 min read
Copper Peptide GHK-Cu: Science, Benefits & Skin, Hair, Health Effects in 2026

My Store Admin · 22 May 2026 · 4 min read
Synthetic Peptides Guide 2026: Uses, Safety & Scientific Insights

My Store Admin · 17 May 2026 · 9 min read
The Triple Agonist: Retatrutide & the Next Frontier of Weight Loss
Retatrutide is Eli Lilly's experimental once-weekly injectable drug that targets three hormone receptors simultaneously — GLP-1, GIP, and glucagon — making it the first of its kind. In its first Phase 3 trial (TRIUMPH-4), patients on the highest dose lost an average of 28.7% of their body weight (roughly 71 pounds) over 68 weeks, while also seeing dramatic reductions in knee pain. These numbers surpass every weight-loss drug currently on the market, including tirzepatide (Zepbound) and semaglutide (Wegovy). Beyond weight loss, the drug improved blood pressure, cholesterol, and inflammation markers. A new side effect — abnormal skin sensation (dysesthesia) — emerged in Phase 3 and will be closely watched. Seven more Phase 3 trials are expected to report results throughout 2026, with FDA approval possible as early as 2027. Retatrutide is not yet available and remains investigational.

My Store Admin · 17 May 2026 · 12 min read
BPC-157: The Body's Own Healing Peptide — What the Science Actually Says
BPC-157 is a synthetic 15-amino-acid peptide derived from human gastric juice that has shown remarkable healing properties across 30 years of animal research — accelerating tendon repair, protecting the gut lining, reducing inflammation, and supporting neurological recovery. It works primarily by triggering new blood vessel growth, driving cell migration to injury sites, and modulating inflammatory cytokines without suppressing the healing process. The animal data is extensive and consistently positive. The human data, however, is nearly nonexistent — fewer than 30 people have ever been studied in published trials, a pivotal 2015 Phase 1 safety study was cancelled with no explanation, and no randomized controlled trials exist. The FDA classified it as a Category 2 substance in 2023, meaning it cannot be legally compounded. Despite this, it is widely sold online as a research chemical with zero quality control oversight. BPC-157 is one of the most scientifically interesting peptides in research today — and one of the least proven in humans.

My Store Admin · 17 May 2026 · 12 min read
Tesamorelin: The FDA-Approved Peptide Quietly Reshaping Metabolic Medicine
Tesamorelin is a synthetic 44-amino acid analogue of Growth Hormone-Releasing Hormone (GHRH), developed by Theratechnologies and FDA-approved since 2010 under the brand name EGRIFTA. It is the only peptide approved in the United States specifically to reduce excess visceral abdominal fat — the dangerous fat surrounding internal organs that drives cardiovascular disease, insulin resistance, and metabolic dysfunction. Unlike GLP-1 drugs that suppress appetite, tesamorelin works upstream at the brain-pituitary axis, restoring the body's own pulsatile growth hormone signaling rather than introducing exogenous hormones directly. Phase 3 trials in HIV lipodystrophy showed 15–19% visceral fat reduction at 26 weeks. A landmark Lancet HIV trial showed 37% relative liver fat reduction at 12 months, with fibrosis progression prevented. Emerging research points to applications in cognitive function, cardiovascular risk, and general metabolic disease. A simplified weekly-reconstitution formulation — EGRIFTA WR — was approved by the FDA in March 2025. In a space filled with unproven peptides, tesamorelin stands alone: it has the trials, the approval, and the documented safety data to back it up

